Cargando…

Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds

Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzuti, Bruno, Ceballos-Laita, Laura, Ortega-Alarcon, David, Jimenez-Alesanco, Ana, Vega, Sonia, Grande, Fedora, Conforti, Filomena, Abian, Olga, Velazquez-Campoy, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465303/
https://www.ncbi.nlm.nih.gov/pubmed/34577592
http://dx.doi.org/10.3390/ph14090892
_version_ 1784572838173212672
author Rizzuti, Bruno
Ceballos-Laita, Laura
Ortega-Alarcon, David
Jimenez-Alesanco, Ana
Vega, Sonia
Grande, Fedora
Conforti, Filomena
Abian, Olga
Velazquez-Campoy, Adrian
author_facet Rizzuti, Bruno
Ceballos-Laita, Laura
Ortega-Alarcon, David
Jimenez-Alesanco, Ana
Vega, Sonia
Grande, Fedora
Conforti, Filomena
Abian, Olga
Velazquez-Campoy, Adrian
author_sort Rizzuti, Bruno
collection PubMed
description Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K(i) = 0.81 μM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K(i) = 4.1 μM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.
format Online
Article
Text
id pubmed-8465303
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84653032021-09-27 Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds Rizzuti, Bruno Ceballos-Laita, Laura Ortega-Alarcon, David Jimenez-Alesanco, Ana Vega, Sonia Grande, Fedora Conforti, Filomena Abian, Olga Velazquez-Campoy, Adrian Pharmaceuticals (Basel) Article Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K(i) = 0.81 μM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K(i) = 4.1 μM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds. MDPI 2021-09-01 /pmc/articles/PMC8465303/ /pubmed/34577592 http://dx.doi.org/10.3390/ph14090892 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rizzuti, Bruno
Ceballos-Laita, Laura
Ortega-Alarcon, David
Jimenez-Alesanco, Ana
Vega, Sonia
Grande, Fedora
Conforti, Filomena
Abian, Olga
Velazquez-Campoy, Adrian
Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
title Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
title_full Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
title_fullStr Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
title_full_unstemmed Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
title_short Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds
title_sort sub-micromolar inhibition of sars-cov-2 3clpro by natural compounds
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465303/
https://www.ncbi.nlm.nih.gov/pubmed/34577592
http://dx.doi.org/10.3390/ph14090892
work_keys_str_mv AT rizzutibruno submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT ceballoslaitalaura submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT ortegaalarcondavid submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT jimenezalesancoana submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT vegasonia submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT grandefedora submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT confortifilomena submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT abianolga submicromolarinhibitionofsarscov23clprobynaturalcompounds
AT velazquezcampoyadrian submicromolarinhibitionofsarscov23clprobynaturalcompounds